Study in Healthy Adults to Quantify Lung Deposition and Distribution of Radio-labelled S-770108 Inhalation Powder Formulation Delivered by a Novel Inhaler Device

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

December 21, 2020

Conditions

Healthy Volunteer

Interventions

DRUG

Radio-labelled S-770108

99mTc radio-labelled S-770108 supplied as a capsule containing 6 mg active pirfenidone for inhalation

DEVICE

S-770108 Inhaler A1

Dry powder inhaler

Trial Locations (1)

Simbec-Orion, Merthyr Tydfil